Antigen Groups and Transfusion Reactions Flashcards

1
Q

Kell

A
  • IgG
  • Reacts with AHG
  • Enzymes have no effect
  • Causes: HTR, HDN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Duffy

A
  • IgG
  • Reacts with AHG
  • Destroyed by enzyme
  • Causes: HTR, HDN (expressed on cord cells)
  • Other: show dosage effect, glycoprotein is a receptor for P. vivax, the merozoites bind but cannot enter the cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Kidd

A
  • IgG
  • Reacts with AHG
  • Enzymes enhance agglutination
  • Causes: HTR(delayed) and HDN
  • Other: show dosage effect, bind complement, deteriorate in storage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lua

A
  • IgM
  • Reacts at room temp (4C)
  • Enzymes variable
  • Other: Not naturally occurring, not naturally significant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lub

A
  • IgG
  • Reacts with AHG (37C)
  • Enzymes variable
  • Causes: HTR, HDN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lewis

A
  • IgM
  • 4C (Cold reacting)
  • Enzymes cause enhanced agglutination
  • Other: produced by tissues and absorbed onto RBCs, not associated with HDFN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

P

A
  • IgM
  • 4C
  • Other: Reacts at IS, 37C or AHG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

M,N

A
  • IgM
  • Reacts at IS, 37C, or AHG
  • Destroyed by enzymes
  • Other: shows dosage effect; clinically significant if IgG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

S,s

A
  • IgG
  • Reacts at 37C, with AHG
  • Enzymes are variable
  • Causes: HTR, HDN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Types of carrier molecules

A

Most Ag are carried on glycoproteins with a specificity to the Ag

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MNS System

A

Most important transfusion Ag

  1. M/N on Glycophorin A
  2. S on Glycophorin B

M/S and N/s are usually found together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anti-M

A

IAT if IS crossmatch is +

Will not react with enzyme treated cells, but can be enhanced by an acidified environ.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Anti-N

A

Seen in dialysis Pts with residual formaldehyde

Alters the N Ag in the Pt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Anti-Kell

A

Most Immunogenic after ABO and Rh

Can be “naturally occurring” after microbial infections, the IgMs clear after the infection

Other naturally occurring Ab are cold reactive with a negative IAT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

I/i Ag

A
  1. Fetal cells express I antigen
  2. Adults express i Ag

Transition occurs by 18 mos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Anti-I

A

Usually an IgM cold-reactive Ab, found in 4C testing

Rarely found as an autoanti-I at 37C from complement binding at RT that carry over to IAT, these can cause Cold Agglutinin Syndrome:

  • May be helpful to use a monospecific IgG reagent
  • O cells run at RT and 4C can ID cold-agglutinins
  • Prewarming techniques can remove cold-agglutinins, but are usually not used
17
Q

Increase in Temp of 1C/chills

A
  • HTR
  • TACO
  • Bacterial Contamination
  • Febrile non-hemolytic transfusion reactions (FNHTR)
18
Q

Hypotension/Tachycardia

A
  • HTR
  • TACO
  • Anaphylaxis
  • Bacterial contamination
  • Air embolus
19
Q

Hypertensive changes

A
  • TACO
  • TRALI
20
Q

Pain/Anxiety

A
  • HTR
  • Febrile Rxn
  • Citrate Rxn
21
Q

Transfusion Reaction Procedural Steps

A
  1. Stop transfusion
  2. Review clerical info
  3. Check for hemolysis in pre/post transfusion samples
  4. Repeat ABO on post- DAT on post-, if +, DAT on most recent pre-

Further testing can include: compatibility testing, Ab screen on post-, eluate, bacteriologic studies, coag studies, plasma Hgb, bilirubin, urinalysis

22
Q

TRALI

A

Transfusion-Related Acute Lung Injury

Severe pulmonary issues within hours of transfusion, with fever

Donor anti-leukocyte Ab activate and aggregate WBCs, or transfusion of cytokines activates neutrophils in the lung present from an underlying condition

23
Q

TACO

A

Transfusion-Assoc. Circulatory Overload

Greatest at risk have underlying heart, lung, or kidney failure that make them intolerant of volume increase; those with massive transfusions, Peds, and severe anemia are also at risk

Show shortness of breath, coughing, elevated BP, low pulse rate, peripheral edema

Respond to diuretics (helps diagnose as well), ventilation/oxygen, slow transfusion of blood products helps prevent this

24
Q

Anaphylotoxins C5a/C3a

A

Promote release of serotonin/histamine from Mast Cells, causing smooth muscle contractions and bronchial/vascular dilation

Show hyptotension, chills, fever, back pain, shock, renal failure and death

25
Intra/Extravascular Hemolysis
Both show hemoglobinemia, hemoglobinuria, increased plasma Hgb, low serum haptoglobin, increase indirect bilirubin From non-ABO Ab-related hemolysis or a drop in Ab titer below detection level
26
DHTR
Delayed Hemolytic Transfusion Reaction Extravascular hemolysis weeks after transfusion Usually require presensitization via transfusion, transplant, and pregnancy Usually from **Kidd, Duffy, Kell,** and **MNS** Chronically transfused Sickle Cell Pts may develop alloAb and risk DHTRs
27
Transfusion Related Bacterial Infection
Sepsis, Fever, Hypotension Immunosuppressed Pts may not show a febrile response Can progress to DIC, renal failure, and death Babesia microti has been implicated in a significant # of cases If septic, they should be cultured and started on antibiotic therapy
28
Allergic/Anaphylactic Rxns
**Recipient IgE to soluble Ag in donor plasma,** most commonly in plasma containing platelet products Epinephrine will control the reaction while BP and volume are maintained, steroids may also help
29
FNHTR
**Cytokines released from WBC in storage cause inflame. in recipient** Treated/Prevented with antipyretics
30
TAGVHD
Transmission Assoc. Graft-Versus-Host Disease Non-specific symptoms within weeks of transfusion, will cause death Immunosuppresed, those on chemotherapy, with congenital disorders, and newborns are at greatest risk **Donor T cells attack Pt cells** Use of irradiated units, and those tested for **HLA compatibility**
31
Posttransfusion Purpura
Sudden onset of thrombocytopenia 1-2 weeks after transfusion from platelet-specific Ab in Pt from prior exposure
32
HDFN Prenatal Evaluation
History of pregnancies/transfusions, screening at first prenatal visit for ABO/Rh/Ab screen, no maternal weak D testing needed Screen should be with anti-IgG AHG and without enhancement via enzyme treated cells to detect only Ag assoc. with HDFN
33
Ab titration in HDFN
To assess the relative strength of the Ab Uses dilutions of maternal serum incubated at 37C with reagent RBCs with Ag against maternal Ab, and read at anti-IgG AHG phase Procedure variations include: can be preformed in saline, gel cards, enhancement media, alter incubation times, and different Ag expressed on RBCs Usually predictive in first affected pregnancy and not needed in any subsequent pregnancies
34
Anti-Kell in HDFN
Suppress RBC production by encouraging phagocytosis before the cells produce hemoglobin, leading to anemia and hydrops without a significant titer
35
Intrauterine Transfusions
Administered through the umbilical vein or peritoneal cavity, using fresh O units that are negative for maternal Ag, and irradiated to prevent TAGVHD
36
False Negative in Direct Testing for D Ag
The cells are too coated in maternal Anti-D to agglutinate
37
Quantification of Fetal-Maternal Hemorrhage
Screening Test is the **rosette test** * Maternal sample from 1hr after birth and mixed with Anti-D * Washed and indicator cells are added **Kleihauer-Betke** (based on fetal Hgb resistance to elution from RBCs) acid elution or Flow Cytometry can also be used
38
Previously Sensitized Women (D)
IgG with a titer lower than \< 4, alloimmunization has IgM and a higher titer
39
NAITP
Neonatal Thrombocytopetic Purpura Maternal IgG against fetal platelets, can be in first pregnancies, inter cranial hemorrhage can occur in utero/after delivery Irradiated, leucoreduced, CMV-seronegative, antigen negative platelets can be transfused to prevent hemorrhage